Literature DB >> 11385458

Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases.

S Sasaki1, R R Amara, A E Oran, J M Smith, H L Robinson.   

Abstract

Apoptotic bodies can be used to target delivery of DNA-expressed immunogens into professional antigen-presenting cells (APCs). Here we show that antigen-laden apoptotic bodies created by vectors co-expressing influenza virus hemagglutinin (HA) or nucleoprotein (NP) genes and mutant caspase genes markedly increased T-cell responses. Both CD8 and CD4 T-cell responses were affected. The adjuvant activity was restricted to partially inactivated caspases that allowed immunogen expression before the generation of apoptotic bodies. Active-site mutants of murine caspase 2 and an autocatalytic chimera of murine caspase 2 prodomain and human caspase 3 induced apoptosis that did not interfere with immunogen expression. The adjuvant activity also enhanced B-cell responses, but to a lesser extent than T-cell responses. The large increases in T-cell responses represent one of the strongest effects to date of a DNA adjuvant on cellular immunity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11385458     DOI: 10.1038/89289

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  30 in total

1.  Vaccines to die for.

Authors:  N P Restifo
Journal:  Nat Biotechnol       Date:  2001-06       Impact factor: 54.908

2.  Molecular basis of neurovirulence of flury rabies virus vaccine strains: importance of the polymerase and the glycoprotein R333Q mutation.

Authors:  Lihong Tao; Jinying Ge; Xijun Wang; Hongyue Zhai; Tao Hua; Bolin Zhao; Dongni Kong; Chinglai Yang; Hualan Chen; Zhigao Bu
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

3.  Regulation of DNA-raised immune responses by cotransfected interferon regulatory factors.

Authors:  Shin Sasaki; Rama Rao Amara; Wen-Shuz Yeow; Paula M Pitha; Harriet L Robinson
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

Review 4.  On the use of DNA vaccines for the prophylaxis of mycobacterial diseases.

Authors:  Kris Huygen
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

5.  Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins.

Authors:  Tae Woo Kim; Chien-Fu Hung; Morris Ling; Jeremy Juang; Liangmei He; J Marie Hardwick; Sharad Kumar; T-C Wu
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

6.  DNA vaccines and apoptosis: to kill or not to kill?

Authors:  Wolfgang W Leitner; Nicholas P Restifo
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

7.  Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines.

Authors:  Wolfgang W Leitner; Leroy N Hwang; Elke S Bergmann-Leitner; Steven E Finkelstein; Stephan Frank; Nicholas P Restifo
Journal:  Vaccine       Date:  2004-03-29       Impact factor: 3.641

8.  HIV-1 protease has a genetic T-cell adjuvant effect which is negatively regulated by proteolytic activity.

Authors:  Kwang Soon Kim; Dong Bin Jin; So Shin Ahn; Ki Seok Park; Sang Hwan Seo; You Suk Suh; Young Chul Sung
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

9.  Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity.

Authors:  R Pulmanausahakul; M Faber; K Morimoto; S Spitsin; E Weihe; D C Hooper; M J Schnell; B Dietzschold
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 10.  DNA vaccines against human immunodeficiency virus type 1 in the past decade.

Authors:  Malavika Giri; Kenneth E Ugen; David B Weiner
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.